RxDoctor Payments Data

Reynaldo Dejesus, MD

Neurological Surgery · Ponce, PRNPI 1881791663

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,929 of the $5,129 with a category attached, or 76.6%. 8 manufacturers reported payments, led by Medtronic at 58.7% of the total. Reporting peaked in 2019 at $2,913 and has fallen 87.9% since, to $353 in 2025.

$5,129in general payments, 2019–2025

Across 44 payments — averaging $116.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Globus Medical$2K
  • Johnson & Johnson$325
  • Boston Scientific$108
  • Baxter Healthcare$68
  • Johnson And Johnson International$37
  • plus $68 from 2 others

What the payments were for

  • Travel & lodging$3,92977%
  • Food & beverage$1,19923%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)18$3,009
Globus Medical(2 entities)11$1,514
Johnson & Johnson8$325
Boston Scientific3$108
Baxter Healthcare1$68
Johnson And Johnson International1$37
BD1$34
Neurelis, Inc.1$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,129 in reported general payments places this provider in the 70th percentile of 39 neurological surgery providers in Puerto Rico.

See all neurological surgery providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$8,115
Medicare patients
18
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$354
Gabapentin21$88

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Ponce

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →